The number of recalls in the U.S. have increased steadily in the last few years and, in 2023, reached the highest level since the pandemic, per FDA data. "There's been a 20-25% increase in recalls ...

Debunking claims of safety concerns around Zoetis Inc.'s OA pain drug, Librela. Click here for our updated look at ZTS stock ...

The FDA is alerting veterinarians about reports of health problems in dogs, including hundreds of deaths, tied to a drug for ...

The agency recommended that the maker of Librela update its label to reflect the possibility of more serious adverse reactions.

Channel 2 Action News has learned that the FDA is now alerting veterinarians about reports of health problems in dogs – ...

Last week, the Food and Drug Administration (FDA) published a letter to veterinarians notifying them of severe adverse events ...

The dvm360 editorial team is counting down our Top 20 news stories and articles of the year, from January 1, 2024, to ...

Less than 10% of the millions eligible for the so-called "King Kong of weight loss drugs" will be able to get it in the next three years, according to guidance by the National Institute for Health ...